February 25, 2025 - 01:05

The University of Tennessee Health Science Center has earned the prestigious R1 designation from the Carnegie Classification of Institutions of Higher Education. This recognition places the institution among the top research universities in the United States, highlighting its commitment to excellence in scientific research and education.
The R1 designation is awarded to universities that demonstrate the highest level of research activity. This achievement reflects the hard work and dedication of faculty, staff, and students who contribute to innovative research projects and community health initiatives. The designation is not only a point of pride for the university but also enhances its ability to attract funding, top-tier faculty, and talented students.
As an R1 institution, the University of Tennessee Health Science Center is poised to make significant contributions to the fields of medicine, health sciences, and public health. This recognition underscores its role as a leader in advancing knowledge and improving health outcomes for communities both locally and globally.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....